Essec\Faculty\Model\Contribution {#2233
  #_index: "academ_contributions"
  #_id: "13856"
  #_source: array:26 [
    "id" => "13856"
    "slug" => "reduced-rate-of-acute-diabetes-events-with-flash-glucose-monitoring-is-sustained-for-2-years-after-initiation-extended-outcomes-from-the-relief-study"
    "yearMonth" => "2022-08"
    "year" => "2022"
    "title" => "Reduced Rate of Acute Diabetes Events with Flash Glucose Monitoring Is Sustained for 2 Years After Initiation: Extended Outcomes from the RELIEF Study"
    "description" => "RIVELINE, J.P., ROUSSEL, R., VICAUT, E., PUYOU DE POUVOURVILLE, G., DETOURNAY, B., EMERY, C. ... GUERCI, B. (2022). Reduced Rate of Acute Diabetes Events with Flash Glucose Monitoring Is Sustained for 2 Years After Initiation: Extended Outcomes from the RELIEF Study. <i>Diabetes Technology & Therapeutics</i>, 24(9), pp. 611-618."
    "authors" => array:8 [
      0 => array:3 [
        "name" => "PUYOU DE POUVOURVILLE Gérard"
        "bid" => "B00072308"
        "slug" => "de-pouvourville-gerard"
      ]
      1 => array:1 [
        "name" => "RIVELINE Jean-Pierre"
      ]
      2 => array:1 [
        "name" => "ROUSSEL Ronan"
      ]
      3 => array:1 [
        "name" => "VICAUT Eric"
      ]
      4 => array:1 [
        "name" => "DETOURNAY Bruno"
      ]
      5 => array:1 [
        "name" => "EMERY Corinne"
      ]
      6 => array:1 [
        "name" => "LEVRAT-GUILLEN Fleur"
      ]
      7 => array:1 [
        "name" => "GUERCI Bruno"
      ]
    ]
    "ouvrage" => ""
    "keywords" => []
    "updatedAt" => "2023-03-15 15:43:51"
    "publicationUrl" => "https://doi.org/10.1089/dia.2022.0085"
    "publicationInfo" => array:3 [
      "pages" => "611-618"
      "volume" => "24"
      "number" => "9"
    ]
    "type" => array:2 [
      "fr" => "Articles"
      "en" => "Journal articles"
    ]
    "support_type" => array:2 [
      "fr" => "Revue scientifique"
      "en" => "Scientific journal"
    ]
    "countries" => array:2 [
      "fr" => "États-Unis"
      "en" => "United States of America"
    ]
    "abstract" => array:2 [
      "fr" => """
        Background: The RELIEF study has previously shown a fall in the rate of acute diabetes events (ADEs) in people living with type 1 diabetes (PwDT1) or people living with type 2 diabetes (PwDT2) in the 12 months after initiation of flash glucose monitoring (FLASH) in France. The 2-year follow-up has provided new insights on the frequency of ADEs, including severe hypoglycemia and diabetic ketoacidosis (DKA), during use of FLASH.\n
        \n
        Methods: The RELIEF study included 31,446 PwDT1 and 41,027 PwDT2 with a first delivery of FreeStyle Libre (FSL) between August 1 and December 31, 2017. Hospitalizations for DKA, severe hypoglycemia, diabetes-related coma, and hyperglycemia were recorded for the 12 months before and 24 months after FSL initiation. Persistence of the FSL system use was estimated through a Kaplan–Meier survival curve. Change in usual blood glucose monitoring was estimated through acquisition of blood glucose test strips.\n
        \n
        Results: In the 2 years after FSL initiation, hospitalizations for ADEs were reduced by 49% and by 48% in PwDT1 or PwDT2, respectively, driven by reductions in DKA. After 2 years, 88% of patients persisted with the system and estimated mean consumption of blood glucose test strips had fallen after 2 years by −82% and by −84% in type 1 diabetes mellitus and type 2 diabetes mellitus, respectively.\n
        \n
        Conclusion: Use of FSL consistently reduces the rates of hospitalization for ADEs, mainly DKA, 2 years after initiation, confirming this is not a transitory effect. Use of FSL also results in a clear and progressive drop in use of blood glucose test strips over the 2-year period.
        """
      "en" => """
        Background: The RELIEF study has previously shown a fall in the rate of acute diabetes events (ADEs) in people living with type 1 diabetes (PwDT1) or people living with type 2 diabetes (PwDT2) in the 12 months after initiation of flash glucose monitoring (FLASH) in France. The 2-year follow-up has provided new insights on the frequency of ADEs, including severe hypoglycemia and diabetic ketoacidosis (DKA), during use of FLASH.\n
        \n
        Methods: The RELIEF study included 31,446 PwDT1 and 41,027 PwDT2 with a first delivery of FreeStyle Libre (FSL) between August 1 and December 31, 2017. Hospitalizations for DKA, severe hypoglycemia, diabetes-related coma, and hyperglycemia were recorded for the 12 months before and 24 months after FSL initiation. Persistence of the FSL system use was estimated through a Kaplan–Meier survival curve. Change in usual blood glucose monitoring was estimated through acquisition of blood glucose test strips.\n
        \n
        Results: In the 2 years after FSL initiation, hospitalizations for ADEs were reduced by 49% and by 48% in PwDT1 or PwDT2, respectively, driven by reductions in DKA. After 2 years, 88% of patients persisted with the system and estimated mean consumption of blood glucose test strips had fallen after 2 years by −82% and by −84% in type 1 diabetes mellitus and type 2 diabetes mellitus, respectively.\n
        \n
        Conclusion: Use of FSL consistently reduces the rates of hospitalization for ADEs, mainly DKA, 2 years after initiation, confirming this is not a transitory effect. Use of FSL also results in a clear and progressive drop in use of blood glucose test strips over the 2-year period.
        """
    ]
    "authors_fields" => array:2 [
      "fr" => "Management"
      "en" => "Management"
    ]
    "indexedAt" => "2024-11-25T06:21:50.000Z"
    "docTitle" => "Reduced Rate of Acute Diabetes Events with Flash Glucose Monitoring Is Sustained for 2 Years After Initiation: Extended Outcomes from the RELIEF Study"
    "docSurtitle" => "Articles"
    "authorNames" => "<a href="/cv/de-pouvourville-gerard">PUYOU DE POUVOURVILLE Gérard</a>, RIVELINE Jean-Pierre, ROUSSEL Ronan, VICAUT Eric, DETOURNAY Bruno, EMERY Corinne, LEVRAT-GUILLEN Fleur, GUERCI Bruno"
    "docDescription" => "<span class="document-property-authors">PUYOU DE POUVOURVILLE Gérard, RIVELINE Jean-Pierre, ROUSSEL Ronan, VICAUT Eric, DETOURNAY Bruno, EMERY Corinne, LEVRAT-GUILLEN Fleur, GUERCI Bruno</span><br><span class="document-property-authors_fields">Management</span> | <span class="document-property-year">2022</span>"
    "keywordList" => ""
    "docPreview" => "<b>Reduced Rate of Acute Diabetes Events with Flash Glucose Monitoring Is Sustained for 2 Years After Initiation: Extended Outcomes from the RELIEF Study</b><br><span>2022-08 | Articles </span>"
    "docType" => "research"
    "publicationLink" => "<a href="https://doi.org/10.1089/dia.2022.0085" target="_blank">Reduced Rate of Acute Diabetes Events with Flash Glucose Monitoring Is Sustained for 2 Years After Initiation: Extended Outcomes from the RELIEF Study</a>"
  ]
  +lang: "fr"
  +"_type": "_doc"
  +"_score": 9.012864
  +"parent": null
}